SCOTUS to Hear Generic Drug Maker Liability Case

The U.S. Supreme Court will hear the appeal of a decision awarding $21 million to a woman who suffered severe burns and was rendered permanently blind by the anti-inflammatory drug sulindac after a doctor prescribed it to treat her shoulder pain in 2004, according to the New York Times.

Read more...

Visit other PMG Sites: